Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Linerixibat

Product Specifications

UNSPSC Description

Linerixibat (GSK2330672) is a highly potent, nonabsorbable and orally active apical sodium-dependent bile acid transporter (ASBT) inhibitor with an IC50 of 42 nM human ASBT. Linerixibat can be used as lipid-lowering agent. Linerixibat has the potential for type 2 diabetes and Primary Biliary Cholangitis treatment[1][2][3].

Target Antigen

Apical Sodium-Dependent Bile Acid Transporter

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/GSK2330672.html

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

O=C(O)CC(NCC1=C(OC)C=C(C2=C1)[C@@H](C3=CC=CC=C3)N[C@](CC)(CCCC)CS2(=O)=O)CC(O)=O

Molecular Weight

546.68

References & Citations

[1]Wu Y, et al. Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes. J Med Chem. 2013 Jun 27;56(12):5094-114.|[2]Linerixibat (GSK2330672) granted Orphan Status. September 24, 2019.|[3]Wang Y, et al. HNF4α Regulates CSAD to Couple Hepatic Taurine Production to Bile Acid Synthesis in Mice. Gene Expr. 2018 Aug 22;18(3):187-196.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-16643/Linerixibat-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-16643/Linerixibat-SDS-MedChemExpress.pdf

Clinical Information

Phase 3

CAS Number

1345982-69-5

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CYLC2 Polyclonal Antibody
A58710-100 100 µL

CYLC2 Polyclonal Antibody

Ask
View Details
Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)
MBS1392908-01 0.02 mg (E-Coli)

Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)

Ask
View Details
Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)
MBS1392908-02 0.1 mg (E-Coli)

Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)

Ask
View Details
Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)
MBS1392908-03 0.02 mg (Yeast)

Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)

Ask
View Details
Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)
MBS1392908-04 0.1 mg (Yeast)

Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)

Ask
View Details
Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)
MBS1392908-05 0.02 mg (Baculovirus)

Recombinant Aedes aegypti Ubiquitin-related modifier 1 homolog (AAEL008680)

Ask
View Details